S&P 500   4,300.34 (+0.47%)
DOW   33,929.32 (+0.50%)
QQQ   333.39 (+0.91%)
AAPL   173.26 (+0.67%)
MSFT   293.65 (+0.60%)
META   181.10 (+0.33%)
GOOGL   122.13 (+0.37%)
AMZN   143.48 (-0.05%)
TSLA   934.84 (+3.86%)
NVDA   190.20 (+1.66%)
NIO   21.39 (+1.33%)
BABA   94.45 (-0.34%)
AMD   101.26 (+0.43%)
MU   64.82 (-0.34%)
T   18.42 (+0.82%)
CGC   3.86 (+16.97%)
GE   79.80 (-0.16%)
F   16.38 (+1.24%)
DIS   124.39 (+2.32%)
AMC   23.62 (-3.36%)
PYPL   102.08 (+0.97%)
PFE   49.83 (-0.56%)
NFLX   250.31 (+0.41%)
S&P 500   4,300.34 (+0.47%)
DOW   33,929.32 (+0.50%)
QQQ   333.39 (+0.91%)
AAPL   173.26 (+0.67%)
MSFT   293.65 (+0.60%)
META   181.10 (+0.33%)
GOOGL   122.13 (+0.37%)
AMZN   143.48 (-0.05%)
TSLA   934.84 (+3.86%)
NVDA   190.20 (+1.66%)
NIO   21.39 (+1.33%)
BABA   94.45 (-0.34%)
AMD   101.26 (+0.43%)
MU   64.82 (-0.34%)
T   18.42 (+0.82%)
CGC   3.86 (+16.97%)
GE   79.80 (-0.16%)
F   16.38 (+1.24%)
DIS   124.39 (+2.32%)
AMC   23.62 (-3.36%)
PYPL   102.08 (+0.97%)
PFE   49.83 (-0.56%)
NFLX   250.31 (+0.41%)
S&P 500   4,300.34 (+0.47%)
DOW   33,929.32 (+0.50%)
QQQ   333.39 (+0.91%)
AAPL   173.26 (+0.67%)
MSFT   293.65 (+0.60%)
META   181.10 (+0.33%)
GOOGL   122.13 (+0.37%)
AMZN   143.48 (-0.05%)
TSLA   934.84 (+3.86%)
NVDA   190.20 (+1.66%)
NIO   21.39 (+1.33%)
BABA   94.45 (-0.34%)
AMD   101.26 (+0.43%)
MU   64.82 (-0.34%)
T   18.42 (+0.82%)
CGC   3.86 (+16.97%)
GE   79.80 (-0.16%)
F   16.38 (+1.24%)
DIS   124.39 (+2.32%)
AMC   23.62 (-3.36%)
PYPL   102.08 (+0.97%)
PFE   49.83 (-0.56%)
NFLX   250.31 (+0.41%)
S&P 500   4,300.34 (+0.47%)
DOW   33,929.32 (+0.50%)
QQQ   333.39 (+0.91%)
AAPL   173.26 (+0.67%)
MSFT   293.65 (+0.60%)
META   181.10 (+0.33%)
GOOGL   122.13 (+0.37%)
AMZN   143.48 (-0.05%)
TSLA   934.84 (+3.86%)
NVDA   190.20 (+1.66%)
NIO   21.39 (+1.33%)
BABA   94.45 (-0.34%)
AMD   101.26 (+0.43%)
MU   64.82 (-0.34%)
T   18.42 (+0.82%)
CGC   3.86 (+16.97%)
GE   79.80 (-0.16%)
F   16.38 (+1.24%)
DIS   124.39 (+2.32%)
AMC   23.62 (-3.36%)
PYPL   102.08 (+0.97%)
PFE   49.83 (-0.56%)
NFLX   250.31 (+0.41%)
Most-Upgraded Stocks  
NYSE:CI

Cigna - CI Stock Forecast, Price & News

$291.15
+0.23 (+0.08%)
(As of 08/15/2022 03:33 PM ET)
Add
Compare
Today's Range
$288.10
▼
$293.49
50-Day Range
$242.23
▼
$290.92
52-Week Range
$191.74
▼
$291.39
Volume
53,585 shs
Average Volume
1.78 million shs
Market Capitalization
$88.83 billion
P/E Ratio
17.36
Dividend Yield
1.54%
Price Target
$307.82

Cigna MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
5.6% Upside
$307.82 Price Target
Short Interest
Healthy
2.20% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.19
Upright™ Environmental Score
News Sentiment
0.19mentions of Cigna in the last 14 days
Based on 44 Articles This Week
Insider Trading
Selling Shares
$23 M Sold Last Quarter
Proj. Earnings Growth
10.23%
From $22.98 to $25.33 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.85 out of 5 stars

Finance Sector

136th out of 929 stocks

Hospital & Medical Service Plans Industry

3rd out of 11 stocks

See Top Rated MarketRank™ Stocks Here
CI stock logo

About Cigna (NYSE:CI) Stock

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CI. Barclays boosted their price objective on shares of Cigna from $275.00 to $310.00 and gave the company an "overweight" rating in a report on Monday, May 23rd. Mizuho raised their target price on Cigna from $291.00 to $330.00 and gave the company a "buy" rating in a research note on Friday, August 5th. Bank of America upgraded Cigna from an "underperform" rating to a "neutral" rating and lifted their price target for the company from $265.00 to $300.00 in a research note on Thursday, May 26th. The Goldman Sachs Group lifted their price target on shares of Cigna from $273.00 to $311.00 and gave the stock a "neutral" rating in a report on Tuesday, August 9th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Cigna from $236.00 to $284.00 in a research report on Thursday, June 9th. Seven research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $304.67.

Cigna Stock Performance

CI Stock traded up $0.52 on Monday, hitting $291.44. The company had a trading volume of 15,529 shares, compared to its average volume of 1,782,707. Cigna has a 12-month low of $191.74 and a 12-month high of $291.39. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.67. The stock's 50-day simple moving average is $267.73 and its 200 day simple moving average is $253.61. The stock has a market cap of $88.92 billion, a price-to-earnings ratio of 17.37, a P/E/G ratio of 1.14 and a beta of 0.73.

Cigna (NYSE:CI - Get Rating) last issued its earnings results on Thursday, August 4th. The health services provider reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.62 by $0.60. Cigna had a net margin of 3.05% and a return on equity of 15.91%. The company had revenue of $45.48 billion for the quarter, compared to analysts' expectations of $44.34 billion. During the same quarter last year, the company posted $5.24 earnings per share. The firm's quarterly revenue was up 5.4% on a year-over-year basis. As a group, equities research analysts expect that Cigna will post 22.98 earnings per share for the current fiscal year.

Cigna Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 22nd. Shareholders of record on Wednesday, September 7th will be given a $1.12 dividend. The ex-dividend date of this dividend is Tuesday, September 6th. This represents a $4.48 annualized dividend and a yield of 1.54%. Cigna's payout ratio is presently 26.71%.

Insiders Place Their Bets

In other Cigna news, EVP Paul A. Sanford sold 374 shares of the stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $285.00, for a total value of $106,590.00. Following the transaction, the executive vice president now directly owns 9,121 shares in the company, valued at $2,599,485. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Paul A. Sanford sold 374 shares of the firm's stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $285.00, for a total transaction of $106,590.00. Following the sale, the executive vice president now directly owns 9,121 shares in the company, valued at approximately $2,599,485. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Cordani sold 45,261 shares of the firm's stock in a transaction on Tuesday, May 17th. The shares were sold at an average price of $270.42, for a total transaction of $12,239,479.62. Following the sale, the chief executive officer now owns 160,499 shares in the company, valued at $43,402,139.58. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 84,060 shares of company stock worth $22,996,508. Company insiders own 0.80% of the company's stock.

Receive CI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cigna and its competitors with MarketBeat's FREE daily newsletter.

CI Stock News Headlines

August 15, 2022 | marketbeat.com
The Five Hottest Calls From The Q2 Earnings Season  (CI)
These are the five hottest analysts' calls of the 2nd quarter earnings reporting season and all stocks are set up for gains in the back half of the year.
August 9, 2022 | marketbeat.com
Are Medtronic And Intuitive Surgical Poised For Big Growth? (CI)
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
August 15, 2022 | Investing Daily (Ad)
Apple’s Next “Star Product” Could Replace The iPhone?
Apple's next "star product" could be its most profitable yet & may dominate a fast-growing new industry that Morgan Stanley projects will be worth a stunning $10 trillion! The new “profit machine” could hand early investors a $190,717 payday. How can you lock in your shot to 20X your money?  See Here. pixel
August 4, 2022 | marketbeat.com
Clorox, Hostess fall; MGM, Cigna rise
Stocks that traded heavily or had substantial price changes Thursday: Clorox, Hostess fall; MGM, Cigna rise
August 14, 2022 | americanbankingnews.com
SVB Leerink Analysts Lift Earnings Estimates for Cigna Co. (NYSE:CI)
August 13, 2022 | americanbankingnews.com
Cigna (NYSE:CI) Price Target Raised to $305.00
August 13, 2022 | americanbankingnews.com
Cigna Co. (NYSE:CI) EVP Paul A. Sanford Sells 374 Shares
August 13, 2022 | americanbankingnews.com
Hoeltzel Mary T. Agoglia Sells 7,044 Shares of Cigna Co. (NYSE:CI) Stock
August 15, 2022 | Stansberry Research (Ad)
Here's Bill Bonner's "4th and Final Prediction"
One of America's most successful entrepreneurs goes public with "4th and Final Prediction." His first three all came true—will this one too?
August 12, 2022 | americanbankingnews.com
The Goldman Sachs Group Raises Cigna (NYSE:CI) Price Target to $311.00
August 11, 2022 | americanbankingnews.com
Wells Fargo & Company Boosts Cigna (NYSE:CI) Price Target to $319.00
August 11, 2022 | americanbankingnews.com
Oppenheimer Boosts Cigna (NYSE:CI) Price Target to $320.00
August 10, 2022 | finance.yahoo.com
Cigna Corporation (CI) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
August 10, 2022 | nasdaq.com
Cigna Corporation (CI) Hits Fresh High: Is There Still Room to Run? - Nasdaq
August 10, 2022 | finance.yahoo.com
Cigna Corporation (CI) Hits Fresh High: Is There Still Room to Run?
August 10, 2022 | americanbankingnews.com
UBS Group Increases Cigna (NYSE:CI) Price Target to $330.00
August 10, 2022 | americanbankingnews.com
Q3 2022 Earnings Estimate for Cigna Co. (NYSE:CI) Issued By Oppenheimer
August 10, 2022 | americanbankingnews.com
Oppenheimer Increases Cigna (NYSE:CI) Price Target to $320.00
August 9, 2022 | nasdaq.com
Are Finance Stocks Lagging Cigna (CI) This Year? - Nasdaq
August 9, 2022 | finance.yahoo.com
Are Finance Stocks Lagging Cigna (CI) This Year?
August 9, 2022 | finance.yahoo.com
Is Most-Watched Stock Cigna Corporation (CI) Worth Betting on Now?
August 9, 2022 | americanbankingnews.com
Cigna (NYSE:CI) Given New $329.00 Price Target at Credit Suisse Group
August 9, 2022 | americanbankingnews.com
Cigna (NYSE:CI) PT Raised to $294.00
August 8, 2022 | finance.yahoo.com
Credit Suisse Lifts Price Targets For Drug Distributors After Solid Q2 Performance
August 7, 2022 | americanbankingnews.com
Mizuho Increases Cigna (NYSE:CI) Price Target to $330.00
August 6, 2022 | americanbankingnews.com
Cigna (NYSE:CI) Reaches New 52-Week High Following Better-Than-Expected Earnings
August 6, 2022 | americanbankingnews.com
Cigna Co. (NYSE:CI) EVP Sells $247,129.96 in Stock
See More Headlines
Receive CI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cigna and its competitors with MarketBeat's FREE daily newsletter.

CI Company Calendar

Ex-Dividend for 6/23 Dividend
6/07/2022
Dividend Payable
6/23/2022
Last Earnings
8/04/2022
Today
8/15/2022
Ex-Dividend for 9/22 Dividend
9/06/2022
Dividend Payable
9/22/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Sector
Finance
Current Symbol
NYSE:CI
CUSIP
12550910
CIK
701221
Web
www.cigna.com
Phone
(860) 226-6000
Fax
860-226-6741
Employees
73,700
Year Founded
1981

Price Target and Rating

Average Stock Price Forecast
$307.82
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$270.00
Forecasted Upside/Downside
+5.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
21 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$16.77
Trailing P/E Ratio
17.36
Forward P/E Ratio
12.67
P/E Growth
1.14
Net Income
$5.37 billion
Net Margins
3.05%
Pretax Margin
3.85%
Return on Equity
15.91%
Return on Assets
4.83%

Debt

Debt-to-Equity Ratio
0.67
Current Ratio
0.72
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$174.08 billion
Price / Sales
0.51
Cash Flow
$29.89 per share
Price / Cash Flow
9.74
Book Value
$142.20 per share
Price / Book
2.05

Miscellaneous

Outstanding Shares
305,116,000
Free Float
302,675,000
Market Cap
$88.83 billion
Optionable
Optionable
Beta
0.73

Social Links


Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CI Stock - Frequently Asked Questions

Should I buy or sell Cigna stock right now?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cigna in the last twelve months. There are currently 7 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CI shares.
View CI analyst ratings or view top-rated stocks.

What is Cigna's stock price forecast for 2022?

21 brokerages have issued twelve-month price objectives for Cigna's stock. Their CI share price forecasts range from $270.00 to $330.00. On average, they anticipate the company's stock price to reach $307.82 in the next twelve months. This suggests a possible upside of 5.7% from the stock's current price.
View analysts price targets for CI or view top-rated stocks among Wall Street analysts.

How have CI shares performed in 2022?

Cigna's stock was trading at $229.63 at the start of the year. Since then, CI shares have increased by 26.8% and is now trading at $291.25.
View the best growth stocks for 2022 here.

Are investors shorting Cigna?

Cigna saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 6,870,000 shares, a decrease of 12.9% from the July 15th total of 7,890,000 shares. Based on an average daily trading volume, of 1,960,000 shares, the days-to-cover ratio is presently 3.5 days. Approximately 2.2% of the shares of the stock are short sold.
View Cigna's Short Interest.

When is Cigna's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our CI earnings forecast.

How were Cigna's earnings last quarter?

Cigna Co. (NYSE:CI) announced its quarterly earnings results on Thursday, August, 4th. The health services provider reported $6.22 earnings per share for the quarter, beating analysts' consensus estimates of $5.62 by $0.60. The health services provider had revenue of $45.48 billion for the quarter, compared to analysts' expectations of $44.34 billion. Cigna had a net margin of 3.05% and a trailing twelve-month return on equity of 15.91%. The business's revenue was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.24 earnings per share.
Read the conference call transcript.

How often does Cigna pay dividends? What is the dividend yield for Cigna?

Cigna announced a quarterly dividend on Wednesday, July 27th. Stockholders of record on Wednesday, September 7th will be paid a dividend of $1.12 per share on Thursday, September 22nd. This represents a $4.48 annualized dividend and a dividend yield of 1.54%. The ex-dividend date is Tuesday, September 6th.
Read our dividend analysis for CI.

Is Cigna a good dividend stock?

Cigna (NYSE:CI) pays an annual dividend of $4.48 per share and currently has a dividend yield of 1.54%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 26.71%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CI will have a dividend payout ratio of 17.69% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CI.

What guidance has Cigna issued on next quarter's earnings?

Cigna issued an update on its FY 2022 earnings guidance on Thursday, August, 11th. The company provided EPS guidance of $22.90- for the period, compared to the consensus EPS estimate of $22.72. The company issued revenue guidance of $178.00B-, compared to the consensus revenue estimate of $178.59 billion.

What is David Cordani's approval rating as Cigna's CEO?

1,329 employees have rated Cigna Chief Executive Officer David Cordani on Glassdoor.com. David Cordani has an approval rating of 91% among the company's employees. This puts David Cordani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cigna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cigna investors own include NVIDIA (NVDA), Walt Disney (DIS), Bank of America (BAC), Salesforce (CRM), Alibaba Group (BABA), CVS Health (CVS), UnitedHealth Group (UNH), Intel (INTC), Johnson & Johnson (JNJ) and Micron Technology (MU).

What is Cigna's stock symbol?

Cigna trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

Who are Cigna's major shareholders?

Cigna's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Dodge & Cox (5.46%), FMR LLC (4.68%), Massachusetts Financial Services Co. MA (3.93%), Nordea Investment Management AB (1.09%), Northern Trust Corp (1.08%) and Deutsche Bank AG (0.51%). Insiders that own company stock include David Cordani, Donna F Zarcone, Elder Granger, Eric J Foss, Eric P Palmer, Everett Neville, Hoeltzel Mary T Agoglia, Jason D Sadler, John M Murabito, John Partridge, Matthew G Manders, Michael W Triplett, Nicole S Jones, Paul A Sanford, Steven B Miller, Timothy C Wentworth and William L Roper.
View institutional ownership trends.

How do I buy shares of Cigna?

Shares of CI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cigna's stock price today?

One share of CI stock can currently be purchased for approximately $291.25.

How much money does Cigna make?

Cigna (NYSE:CI) has a market capitalization of $88.87 billion and generates $174.08 billion in revenue each year. The health services provider earns $5.37 billion in net income (profit) each year or $16.77 on an earnings per share basis.

How many employees does Cigna have?

The company employs 73,700 workers across the globe.

Does Cigna have any subsidiaries?

The following companies are subsidiares of Cigna: Accredo Health Group, Accredo Health Incorporated, Alegis Care, Allegiance Life & Health Insurance Company, Allegiance Re, American Retirement Life Insurance Company, Benefits Management Corp., Bravo Health Mid-Atlantic, Bravo Health Pennsylvania, Brighter, CareAllies, CareCore National LLC, Central Reserve Life Insurance Company, Ceres Sales of Ohio, Choicelinx, Cigna & CMB Life Insurance Company Limited, Cigna Apac Holdings Limited, Cigna Arbor Life Insurance Company, Cigna Beechwood Holdings, Cigna Behavioral Health, Cigna Behavioral Health of California, Cigna Behavioral Health of Texas, Cigna Bellevue Alpha, Cigna Benefits Financing, Cigna Brokerage & Marketing (Thailand) Limited, Cigna Cedar Holdings, Cigna Chestnut Holdings, Cigna Corporate Services, Cigna Data Services (Shanghai) Company Limited, Cigna Dental Health, Cigna Dental Health Plan of Arizona, Cigna Dental Health of California, Cigna Dental Health of Colorado, Cigna Dental Health of Delaware, Cigna Dental Health of Florida, Cigna Dental Health of Illinois, Cigna Dental Health of Kansas, Cigna Dental Health of Kentucky, Cigna Dental Health of Maryland, Cigna Dental Health of Missouri, Cigna Dental Health of New Jersey, Cigna Dental Health of North Carolina, Cigna Dental Health of Ohio, Cigna Dental Health of Pennsylvania, Cigna Dental Health of Texas, Cigna Dental Health of Virginia, Cigna Elmwood Holdings, Cigna Europe Insurance Company S.A.-N.V., Cigna European Services (UK) Limited, Cigna Finans Emeklilik ve Hayat A.S., Cigna Global Holdings, Cigna Global Insurance Company Limited, Cigna Global Reinsurance Company, Cigna Global Wellbeing Holdings Limited, Cigna Global Wellbeing Solutions Limited, Cigna HLA Technology Services Company Limited, Cigna Health Corporation, Cigna Health Management, Cigna Health Solutions India Pvt. Ltd., Cigna Health and Life Insurance Company, Cigna HealthSpring, Cigna Healthcare Holdings, Cigna Healthcare Mid-Atlantic, Cigna Healthcare of Arizona, Cigna Healthcare of California, Cigna Healthcare of Colorado, Cigna Healthcare of Connecticut, Cigna Healthcare of Florida, Cigna Healthcare of Georgia, Cigna Healthcare of Illinois, Cigna Healthcare of Indiana, Cigna Healthcare of Maine, Cigna Healthcare of Massachusetts, Cigna Healthcare of New Hampshire, Cigna Healthcare of New Jersey, Cigna Healthcare of North Carolina, Cigna Healthcare of Pennsylvania, Cigna Healthcare of South Carolina, Cigna Healthcare of St. Louis, Cigna Healthcare of Tennessee, Cigna Healthcare of Texas, Cigna Healthcare of Utah, Cigna Holding Company, Cigna Holdings, Cigna Holdings Overseas, Cigna Hong Kong Holdings Company Limited, Cigna Insurance Middle East S.A., Cigna Insurance Public Company Limited, Cigna Insurance Services (Europe) Limited, Cigna Intellectual Property, Cigna International Corporation, Cigna International Health Services, Cigna International Health Services BVBA, Cigna International Health Services Kenya Limited, Cigna International Health Services SDN BHD, Cigna International Services, Cigna International Services Australia Pty. Ltd., Cigna Investment Group, Cigna Investments, Cigna Korean Chusik Hoesa, Cigna Laurel Holdings, Cigna Legal Protection UK Ltd., Cigna Life Insurance Company of Canada, Cigna Life Insurance Company of Europe S.A.- N.V., Cigna Life Insurance Company of New York, Cigna Life Insurance New Zealand Limited, Cigna Linden Holdings, Cigna Magnolia Holdings, Cigna Myrtle Holdings, Cigna Nederland Alpha Cooperatief U.A., Cigna Nederland Beta B.V., Cigna Nederland Gamma B.V., Cigna Oak Holdings, Cigna Palmetto Holdings, Cigna Poplar Holdings, Cigna Sequoia Holdings, Cigna Spruce Holdings GmbH, Cigna Taiwan Life Assurance Company Limited, Cigna Walnut Holdings, Cigna Willow Holdings, Cigna Worldwide General Insurance Company Limited, Cigna Worldwide Insurance Company, Cigna Worldwide Life Insurance Company Limited, CignaTTK Health Insurance Company Limited, Connecticut General Corporation, Connecticut General Life Insurance Company, CuraScript Inc., E-2 CIGNA CORPORATION - 2018 Form 10-K, ESI Mail Pharmacy Service Inc., ESI Partnership, ESI Resources Inc., Express Scripts Holding Company, Express Scripts Inc., Express Scripts Pharmaceutical LLC, Express Scripts Pharmacy Inc., Express Scripts Strategic Development Inc., FirstAssist Administration Limited, Firstassist Insurance Services Ltd, Great-West Healthcare of Illinois, Grown Ups New Zealand Limited, Health-Lynx LLC, HealthSource, HealthSpring, HealthSpring Life & Health Insurance Company, HealthSpring of Alabama, HealthSpring of Florida, HealthSpring of Tennessee, KDM Thailand Limited, LINA Financial Services, LINA Life Insurance Company of Korea, Life Insurance Company of North America, Loyal American Life Insurance Company, MCC Independent Practice Association of New York, Manipal Cigna Health Insurance Company Limited, Medco Containment Life Insurance Company, Medco Health Services Inc., Medco Health Solutions Inc., NewQuest, NewQuest Management Northeast, Olympic Health Management Services, Oz Parent, PT Asuransi Cigna, Provident American Life and Health Insurance Company, Qualcare, Qualcare Alliance Networks, Qualcare Captive Insurance Company Inc. PCC, Qualcare Management Resources Limited Liability Company, RHP (Thailand) Limited, Scibal Associates, Sterling Life Insurance Company, Tel-Drug, Tel-Drug of Pennsylvania, Temple Insurance Company Limited, United Benefit Life Insurance Company, Verity Solutions Group, Zurich Insurance Middle East, and eviCore 1 LLC.
Read More

When was Cigna founded?

Cigna was founded in 1981.

How can I contact Cigna?

Cigna's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The official website for the company is www.cigna.com. The health services provider can be reached via phone at (860) 226-6000, via email at william.mcdowell2@cigna.com, or via fax at 860-226-6741.

This page (NYSE:CI) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.